Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

SELL
$127.59 - $203.08 $754,439 - $1.2 Million
-5,913 Reduced 34.48%
11,234 $2.28 Million
Q4 2022

Feb 14, 2023

SELL
$117.37 - $139.17 $87,323 - $103,542
-744 Reduced 4.16%
17,147 $2.2 Million
Q3 2022

Nov 18, 2022

BUY
$135.27 - $180.11 $61,412 - $81,769
454 Added 2.6%
17,891 $2.45 Million
Q2 2022

Aug 10, 2022

SELL
$108.81 - $179.33 $3,808 - $6,276
-35 Reduced 0.2%
17,437 $3.09 Million
Q1 2022

May 13, 2022

BUY
$119.61 - $157.85 $125,112 - $165,111
1,046 Added 6.37%
17,472 $2.52 Million
Q4 2021

Feb 14, 2022

BUY
$142.57 - $190.86 $1.98 Million - $2.65 Million
13,887 Added 546.95%
16,426 $2.54 Million
Q4 2021

Feb 10, 2022

BUY
$142.57 - $190.86 $361,985 - $484,593
2,539 New
2,539 $16.4 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Industrial Alliance Investment Management Inc. Portfolio

Follow Industrial Alliance Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Industrial Alliance Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Industrial Alliance Investment Management Inc. with notifications on news.